Fixed dose rasburicase

Author: eukq

August undefined, 2024

WebMay 26, 2024 · We analyzed the efficacy of single low dose rasburicase 1.5 mg irrespective of bodyweight in adults and in children a dose of 0.15 mg/kg (maximum 1.5 mg) … Web12. Liu CY1, Sims-McCallum RP et al. A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy. Leuk Res. 2005 Apr;29(4):463-5.Epub 2004 Dec8. 13. Trifilio S, Gordon L, Singhal S et al. Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia.

The efficacy and cost-impact of rasburicase 3 mg versus 6 mg for …

WebJun 13, 2005 · Rasburicase is a recombinant form of urate-oxidase enzyme used to treat hyperuricemia following chemotherapy for leukemias and non-Hodgkin's lymphoma. … WebMost of the data for single-dose rasburicase are retrospective reviews based on single-institution experiences using fixed doses of rasburicase ranging from 1.5 to 7.5 mg, 11-13 and 1 prospective study using a historical control group. 14 Repeat doses may be given based on continued serum uric acid level monitoring. 11,12 truthcontest read the present

Fixed, low-dose rasburicase for the treatment or …

WebLearn more about the nature of hyperuricemia and its various treatment options. WebThe only patient who did not respond to the single 6-mg rasburicase dose was a morbidly obese man (259 kg, body mass index 87 kg/m2) who subsequently responded to an additional dose of rasburicase 12 mg. These results warrant further investigation of a single 6-mg dose of rasburicase in adults with TLS or at high-risk for developing TLS. WebOur results demonstrate that a single fixed dose of rasburicase 3 mg, repeated if required, should be the standard regimen in the management of TLS. Recent studies and published guidelines have shown cumulative … truth consulting

Elitek (rasburicase) dose, indications, adverse effects, interactions ...

Fixed dose rasburicase

Rasburicase - an overview ScienceDirect Topics

WebJun 1, 2011 · It is concluded that a single 3-mg dose of rasburicase, used with close monitoring, is sufficient to treat most adults with uric acid levels up to 12 mg/dL, and continues to decline beyond 24 h in most patients without additional treatment. Rasburicase was administered at a fixed dose of 3 mg to treat 287 episodes of elevated serum uric … WebControl subjects received a single 0.15-mg/kg dose of rasburicase. Measurements and main results: Uric acid levels were measured in all patients at baseline, at 12 and 24 hours after dosing, and then daily. In all patients receiving 7.5 mg, uric acid levels returned to normal at 12 and 24 hours.

Did you know?

WebAug 1, 2010 · The institution guideline indicates rasburicase to be given before the first dose of chemotherapy in patients considered high risk for TLS, and a fixed 3 mg dose of rasBuricase was administered to adult patients, treated at a tertiary referral centre. 24 PDF WebApr 15, 2013 · Rasburicase is a recombinant urate-oxidase enzyme approved by the Food and Drug Administration in 2002 for the treatment of hyperuricemia in patients receiving …

WebEvaluation of a single fixed dose of rasburicase 7.5 mg for the treatment of hyperuricemia in adults with cancer. Pharmacotherapy. 2008;28(6):685–690. 23. Rényi I, Bárdi E, Udvardi E, et al. Prevention … http://site2024.jhoponline.com/issue-archive/2015-issues/june-vol-5-no-2/16423-hyperuricemia-management

WebThe single fixed dose ranged from 0·05 mg/kg to 0·20 mg/kg. The pooled response data for the single dose of rasburicase showed that a single fixed dose was as effective as the prolonged rasburicase treatment … WebRasburicase dosing was at the discretion of the treating clinician, and the initial dose ranged from 1.5 to 16.5 mg. Nine patients had uric acid levels above the normal range …

WebThe labeled dose is 0.2 mg/kg/day administered intravenously over 30 minutes for up to 5 days. Our institutional adult guidelines recommend rasburicase 6 mg for uric acid levels …

WebMar 1, 2011 · The current recommended dose is 0.2 mg/kg/day administered intravenously with the first dose given prior to chemotherapy. ... Shanholtz CB, Thompson JL. Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients. Ann Pharmacother. 2010;44:1529-1537. Uric acid as a weak organic acid (pka 5.8) is … philips easy clean schallzahnbürsteWebA single, 7.5-mg fixed dose of rasburicase was evaluated in a small, prospective, case-controlled study. Most patients in this study received additional supportive care … truth contest and read the presentWebRasburicase is a recombinant urate oxidase enzyme administered for treatment of hyperuricemia associated with tumor lysis syndrome. Studies demonstrate effectiveness of single fixed-dose rasburicase as compared to the FDA-approved dose of 0.2 mg/kg intravenously daily for up to five days. Doses in t … philips easydiagnost eleva drfWebJan 10, 2024 · Rasburicase is a recombinant urate oxidase enzyme used for the treatment and prevention of tumor lysis syndrome. Our objective was to assess the efficacy of … philips easy clean testWebA single, fixed dose of rasburicase (6 mg maximum) for treatment of tumor lysis syndrome in adults A single, fixed dose of rasburicase (6 mg maximum) for treatment of tumor lysis syndrome in adults Eur J Haematol. 2010 Aug;85 (2):177-9. doi: 10.1111/j.1600-0609.2010.01457.x. Epub 2010 Apr 12. Authors Miriam Giraldez , Katarzyna Puto PMID: … truth controlWebJan 20, 2024 · Rasburicase Dosage Medically reviewed by Drugs.com. Last updated on Jan 20, 2024. Applies to the following strengths: 1.5 mg; 7.5 mg Usual Adult Dose for: … philips easy clean sonicareWebRasburicase is a recombinant urate oxidase enzyme approved for use in tumor lysis syndrome (TLS) and it acts by reducing serum uric acid levels. Using rasburicase at the recommended dose of... truth contest